Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersNephrology Physician in Pompano Beach, FL
NPI: 1356378335Primary Practice Location
Springs Dialysis
3890 Park Central N Blvd, Pompano Beach, FL
Primary Employer
Option Care
optioncareltd.com
Looking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
AL State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 29 | 33 |
| 2 | 90935Hemodialysis procedure with one physician evaluation | 24 | 41 |
| 3 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 23 | 44 |
| 4 | 90960Dialysis services (4 or more physician visits per month), patient 20 years of age and older | 16 | 115 |
| 5 | 99223Initial hospital inpatient care, typically 70 minutes per day | 15 | 15 |
Prevalence and prognosis of unrecognized myocardial infarctions in chronic kidney disease.
Clinical Characteristics and Treatment Patterns of Children and Adults With IgA Nephropathy or IgA Vasculitis: Findings From the CureGN Study.
Authors: Kenar Jhaveri, Sandra Iragorri, Sumit Mohan, Carl Cramer, Andrew Bomback, Michelle O'Shaughnessy, Michelle Rheault, Katherine Twombley, Krzysztof Kiryluk, Tetyana Vasylyeva, Bruce Julian, Lisa Guay-Woodford, Sherene Mason, Jan Novak, Donald Weaver, Agnieszka Swiatecka-Urban, Amrish Jain, William Smoyer, Bruce Robinson, Michael Flessner, Aftab Chishti, Ali Gharavi, Myda Khalid, Cynthia D'Alessandri-Silva, Isa Ashoor
Publication Date: 2018-08
A Novel Method for Rapid Bedside Measurement of GFR.
Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Collaborators: Immune Tolerance Network (ITN), GlaxoSmithKline, PPD Development, LP, Rho Federal Systems Division, Inc.
Intervention / Treatment: DRUG: Rituximab, DRUG: Belimumab, DRUG: Placebo for Belimumab
Lead Sponsor: Chinook Therapeutics, Inc.
Intervention / Treatment: DRUG: Placebo, DRUG: Atrasentan
Lead Sponsor: Biogen
Intervention / Treatment: DRUG: Placebo oral capsule, DRUG: Bardoxolone methyl oral capsule